M&A Deal Summary

Synteract Acquires KinderPharm

On November 15, 2018, Synteract acquired life science company KinderPharm

Acquisition Highlights
  • This is Synteract’s 2nd transaction in the Life Science sector.
  • This is Synteract’s 1st transaction in the United States.
  • This is Synteract’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2018-11-15
Target KinderPharm
Sector Life Science
Buyer(s) Synteract
Deal Type Add-on Acquisition

Target

KinderPharm

Exton, Pennsylvania, United States
KinderPharm LLC is a clinical stage, specialty pharmaceutical company focusing exclusively on pediatric drug development providing expert and focused resources. KinderPharm LLC was founded in 2014 and is based in Exton, Pennsylvania.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Synteract

Carlsbad, California, United States

Category Company
Founded 1995
Sector Life Science
DESCRIPTION

Synteract, Inc. is an operator of a full-service international contract research organization (CRO) focused on Phase I?IV clinical trials for emerging to mid-sized biopharma clients in the U.S., Europe, and Asia. Synteract was founded in 1995 and is based in Carlsbad, California.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-01 Harrison Clinical Research

Munich, Germany

Harrison Clinical Research GmbH is a provider of contract clinical research services for clinical research projects in Germany.

Buy -